Hai cercato la traduzione di kinase da Danese a Inglese

fosfoglycerat kinase
phosphoglycerate kinase

pyruvat-kinase
pyruvate kinase

Øget kreatinin - kinase
creatinine phosphokinase increase

blodkreatinfosfo-kinase øget*
blood creatine phosphokinase increased

vægtøgning Øget kreatinin - kinase
investigations

ace er identisk med kinase ii.
ace is identical to kininase ii.

forhøjet serumkreatin- kinase-aktivitet
elevations in serum creatine kinase activity

kreatin kinase målinger og fortolkning:
creatine kinase measurement and interpretation:

oclacitinib er en janus kinase (jak)-hæmmer.
oclacitinib is a janus kinase (jak) inhibitor.

vemurafenib hæmmer braf-serin-treonin-kinase.
vemurafenib is an inhibitor of braf serine-threonine kinase.

hæmolytisk anæmi som følge af pyruvat-kinase-mangel
hemolytic anemia secondary to pyruvate kinase deficiency

bosutinib hæmmer den abnorme bcr-abl-kinase, der fremmer cml.
bosutinib inhibits the abnormal bcr-abl kinase that promotes cml.

iclusig tilhører en gruppe lægemidler, der kaldes tyrosin-kinase-hæmmere.
iclusig belongs to a group of medicines called tyrosine kinase inhibitors.

Øget serum- carbamid, kreatinin og kreatin kinase fald i serum- kalium og natrium
increases in bun, creatinine and creatine kinase decreases in serum potassium and sodium

i sådanne tilfælde skal kreatin kinase (ck) værdier kontrolleres (se nedenfor).
in such cases creatine kinase (ck) levels should be measured (see below).

rutinemonitering af kreatin kinase (ck) eller andre muskelenzymværdier anbefales ikke hos asymptomatiske patienter i statinbehandling.
routine monitoring of creatine kinase (ck) or other muscle enzyme levels is not recommended in asymptomatic patients on statin therapy.

ved at blokere bcr- abl- kinase samt andre kinaser medvirker sprycel til at begrænse spredningen af leukæmicellerne.
by blocking bcr-abl kinase, as well as other kinases, sprycel helps to control the spread of leukaemia cells.

dasatinib virker hovedsagelig ved at blokere en proteinkinase, der kaldes "bcr- abl- kinase".
dasatinib acts mainly by blocking the protein kinase called ‘ bcr-abl’ kinase.

det aktive stof i caprelsa, vandetanib, er en 'protein-tyrosin-kinase-hæmmer'.
the active substance in caprelsa, vandetanib, is a ‘protein tyrosine kinase inhibitor’.

dasatinib virker hoved -sagelig ved at blokere en proteinkinase, der kaldes " bcr-abl-kinase ".
dasatinib acts mainly by blocking the protein kinase called ` bcr-abl'kinase.